Lactylation: a promising therapeutic target in ischemia-reperfusion injury management

Abstract Ischemia-reperfusion injury (IRI) is a critical condition that poses a significant threat to patient safety. The production of lactate increases during the process of IRI, and lactate serves as a crucial indicator for assessing the severity of such injury. Lactylation, a newly discovered po...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei-xiang Wang, Guo Mu, Zi-hang Yu, Zu-an Shi, Xue-xin Li, Xin Fan, Ye Chen, Jun Zhou
Format: Article
Language:English
Published: Nature Publishing Group 2025-03-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02381-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040217069682688
author Fei-xiang Wang
Guo Mu
Zi-hang Yu
Zu-an Shi
Xue-xin Li
Xin Fan
Ye Chen
Jun Zhou
author_facet Fei-xiang Wang
Guo Mu
Zi-hang Yu
Zu-an Shi
Xue-xin Li
Xin Fan
Ye Chen
Jun Zhou
author_sort Fei-xiang Wang
collection DOAJ
description Abstract Ischemia-reperfusion injury (IRI) is a critical condition that poses a significant threat to patient safety. The production of lactate increases during the process of IRI, and lactate serves as a crucial indicator for assessing the severity of such injury. Lactylation, a newly discovered post-translational modification in 2019, is induced by lactic acid and predominantly occurs on lysine residues of histone or nonhistone proteins. Extensive studies have demonstrated the pivotal role of lactylation in the pathogenesis and progression of various diseases, including melanoma, myocardial infarction, hepatocellular carcinoma, Alzheimer’s disease, and nonalcoholic fatty liver disease. Additionally, a marked correlation between lactylation and inflammation has been observed. This article provides a comprehensive review of the mechanism underlying lactylation in IRI to establish a theoretical foundation for better understanding the interplay between lactylation and IRI.
format Article
id doaj-art-0eba87de403f43618bb3cfe38973a649
institution DOAJ
issn 2058-7716
language English
publishDate 2025-03-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-0eba87de403f43618bb3cfe38973a6492025-08-20T02:56:09ZengNature Publishing GroupCell Death Discovery2058-77162025-03-0111111710.1038/s41420-025-02381-4Lactylation: a promising therapeutic target in ischemia-reperfusion injury managementFei-xiang Wang0Guo Mu1Zi-hang Yu2Zu-an Shi3Xue-xin Li4Xin Fan5Ye Chen6Jun Zhou7Department of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityDepartment of Anesthesiology, Fushun County People’s HospitalDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityDepartment of Traditional Chinese Medicine, The Affiliated Hospital, Southwest Medical UniversityDepartment of Anesthesiology, The Affiliated Hospital, Southwest Medical UniversityAbstract Ischemia-reperfusion injury (IRI) is a critical condition that poses a significant threat to patient safety. The production of lactate increases during the process of IRI, and lactate serves as a crucial indicator for assessing the severity of such injury. Lactylation, a newly discovered post-translational modification in 2019, is induced by lactic acid and predominantly occurs on lysine residues of histone or nonhistone proteins. Extensive studies have demonstrated the pivotal role of lactylation in the pathogenesis and progression of various diseases, including melanoma, myocardial infarction, hepatocellular carcinoma, Alzheimer’s disease, and nonalcoholic fatty liver disease. Additionally, a marked correlation between lactylation and inflammation has been observed. This article provides a comprehensive review of the mechanism underlying lactylation in IRI to establish a theoretical foundation for better understanding the interplay between lactylation and IRI.https://doi.org/10.1038/s41420-025-02381-4
spellingShingle Fei-xiang Wang
Guo Mu
Zi-hang Yu
Zu-an Shi
Xue-xin Li
Xin Fan
Ye Chen
Jun Zhou
Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
Cell Death Discovery
title Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
title_full Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
title_fullStr Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
title_full_unstemmed Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
title_short Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
title_sort lactylation a promising therapeutic target in ischemia reperfusion injury management
url https://doi.org/10.1038/s41420-025-02381-4
work_keys_str_mv AT feixiangwang lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT guomu lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT zihangyu lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT zuanshi lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT xuexinli lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT xinfan lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT yechen lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement
AT junzhou lactylationapromisingtherapeutictargetinischemiareperfusioninjurymanagement